Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 1999Journal of Clinical InvestigationOpen Access

p53 and cancer therapy: a double-edged sword

View Full Paper
Ask AI
Bookmark
Share

Authors

GMGaël McGillDFDavid E. Fisher

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

McGill et al. (1999) studied this question.

synapsesocial.com/papers/6aa8d4c2bf083a602da42611https://doi.org/10.1172/jci7861
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas1996 · 100 citations
  2. 2Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.1994 · 541 citations
  3. 3Oncogene-dependent Regulation of Caspase Activation by p53 Protein in a Cell-free System1998 · 92 citations
  4. 4Regulation of Proliferation-Survival Decisions during Tumor Cell Hypoxia1998 · 218 citations